bimatoprost ophthalmic solution 0.03%

DRUG7 trials

Sponsors

Allergan

Conditions

Alopecia AreataCrow's Feet LinesEyelash HypotrichosisFacial RhytidesGlabellar LinesGlaucomaGlaucoma, Open-AngleHypotrichosis

Phase 1

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

CompletedNCT00809848

AllerganGlaucoma, Ocular Hypertension

Start: 2009-02-28End: 2009-05-31Updated: 2013-10-18

Phase 2

Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution

CompletedNCT01001195

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2009-11-30End: 2010-04-30Updated: 2013-10-18

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

CompletedNCT01064882

AllerganEyelash Hypotrichosis

Start: 2010-03-31End: 2010-07-31Updated: 2011-12-09

Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

CompletedNCT01110499

AllerganOcular Hypertension, Primary Open-Angle Glaucoma

Start: 2010-06-30End: 2011-06-30Updated: 2014-08-05

Phase 4

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

CompletedNCT01023841

AllerganAlopecia Areata, Eyelash Hypotrichosis

Start: 2010-06-01End: 2012-11-30Updated: 2019-04-17

Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

CompletedNCT01448525

AllerganHypotrichosis

Start: 2011-10-31End: 2012-04-30Updated: 2013-05-22

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

CompletedNCT02176356

AllerganCrow's Feet Lines, Facial Rhytides, Glabellar Lines +1

Start: 2014-06-30End: 2015-05-03Updated: 2019-01-09